Latest News

Press Release

 “The Second-class Drugs Marketing Authorization Holder” and “The Second-class Medical Devices Marketing Authorization Holder” licenses from Tokyo Metropolitan Government.

February 25, 2010

As a result, RIKEN GENESIS is now authorized to manufacture and market pharmaceutical products including.

Click here for details ▶

 RIKEN GENESIS Collaborates with StaGen to offer SNP Genotyping Service:Comprehensive range of services now includes statistical analysis services based on statistical genetics.

January 27, 2010

Starting on September 1, 2009, RIKEN GENESIS Co., Ltd. completed an agreement with StaGen Co., Ltd. for a business tie-up to offer SNP (single nucleotide polymorphisms) genotyping services.

Click here for details ▶

 SNP-based forensic science research begins through first international cooperation:RIKEN, RIKEN GENESIS and the Netherlands Forensic Institute formulate plan for new forensic science.

October 23, 2009

On October 26, 2009, the RIKEN (Ryoji Noyori, President) Center for Genomic Medicine (Yusuke Nakamura, Director), RIKEN GENESIS Co. Ltd. (Yusuke Tsukahara, President) and the Netherlands Forensic Institute (Tjark Tjin-A-Tsoi, CEO) will sign an agreement for collaborative research on the development of new forensic science technology related to the areas of forensic medicine such as DNA testing.

Click here for details ▶

 Latest genotype analysis system provided to Thailand Clinical research begins to verify the method to guide appropriate use of AIDS drugs based on genetic information.

June 22, 2009

In May 2009, Toppan Printing Co., Ltd. (President & CEO: Naoki Adachi), RIKEN GENESIS CO.,LTD (President & CEO: Yusuke Tsukahara) and RIKEN, Japan (President: Ryoji Noyori) loaned a “TPSA-003” small genotype analysis system (※1) , which can be used in clinical practice, to Ramathibodi Hospital, which is attached to Thailand’s Mahidol University, and trial operation has begun. This system was jointly developed by the 3 companies, targeting the realization of personalized medicine which makes it possible to give treatment matched to the genetic information of the individual. From the end of June, RIKEN and Mahidol University will use the TPSA-003 to jointly conduct full-scale clinical research into how to use AIDS drugs to suit individual patients.

Click here for details ▶

 Business tie-up agreement reached with Beijing Genomics Institute to offer reciprocal contract services.

June 19, 2009

RIKEN GENESIS and Beijing Genomics Institute (headquartered in Shenzhen, China; hereafter BGI) have reached a business tie-up agreement to offer reciprocal services. RIKEN GENESIS offers contract SNP genotyping services, while BGI provides contract DNA sequencing. The two companies have launched the comprehensive provision of their respective world-class services in Japan and China.

This tie-up enables RIKEN GENESIS to offer contract DNA sequencing services in Japan using next-generation sequencers, and to expand its contract SNP genotyping services to China.

Click here for details ▶

Upcoming Conferences and Events

 2010
 2009
The 54th Annual Meeting of the Japan Society of Human Genetics September 24-26

Finished
Tokyo (Takanawa)